Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Clin Nucl Med. 2017 Oct;42(10):735–740. doi: 10.1097/RLU.0000000000001804

Figure 2.

Figure 2

54-year-old man with serum PSA levels of 10.8 ng/mL. T2W MR image (A), axial 18F-DCFBC PET image (B) and fused MR/PET image (C) demonstrate a 1.5 cm low-signal-intensity focus in the apical-mid peripheral zone lesion (arrow), which shows focal intense 18F-DCFBC uptake, with SUVmax up to 4.2. Biopsy confirmed a Gleason 4+4 primary prostate cancer.